First Time Loading...

Tandem Diabetes Care Inc
NASDAQ:TNDM

Watchlist Manager
Tandem Diabetes Care Inc Logo
Tandem Diabetes Care Inc
NASDAQ:TNDM
Watchlist
Price: 37.51 USD 6.44%
Updated: Apr 29, 2024

Tandem Diabetes Care Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tandem Diabetes Care Inc
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Tandem Diabetes Care Inc
NASDAQ:TNDM
Revenue
$747.7m
CAGR 3-Years
14%
CAGR 5-Years
32%
CAGR 10-Years
38%
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.2B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Revenue
$20.5B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

Tandem Diabetes Care Inc
Revenue Breakdown

Breakdown by Geography
Tandem Diabetes Care Inc

Total Revenue: 747.7m USD
100%
United States: 554.9m USD
74.2%
Outside The United States: 192.8m USD
25.8%

Breakdown by Segments
Tandem Diabetes Care Inc

Not Available

See Also

What is Tandem Diabetes Care Inc's Revenue?
Revenue
747.7m USD

Based on the financial report for Dec 31, 2023, Tandem Diabetes Care Inc's Revenue amounts to 747.7m USD.

What is Tandem Diabetes Care Inc's Revenue growth rate?
Revenue CAGR 10Y
38%

Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for Tandem Diabetes Care Inc have been 14% over the past three years , 32% over the past five years , and 38% over the past ten years .